13D/13G Filings - Point72 Asset Management, L.P.

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, ...13, 14, 15, 16, 17, 18, 19, Next
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2022-02-14
4:34 pm
Sale
2021-12-31 13G Allena Pharmaceuticals, Inc.
ALNAQ
Point72 Asset Management, L.P. 0
0.000%
-4,000,000decrease
(Position Closed)
Filing
History
2022-02-14
4:34 pm
Sale
2021-12-31 13G Protagonist Therapeutics, Inc.
PTGX
Point72 Asset Management, L.P. 2,420,309
5.100%
-1,908,721decrease
(-44.09%)
Filing
History
2022-02-14
4:34 pm
Purchase
2021-12-31 13G Affimed N.V.
AFMD
Point72 Asset Management, L.P. 1,185,559
9.900%
604,098increase
(+103.89%)
Filing
History
2022-02-14
4:33 pm
Sale
2021-12-31 13G Regulus Therapeutics Inc.
RGLS
Point72 Asset Management, L.P. 241,158
1.600%
-321,544decrease
(-57.14%)
Filing
History
2022-02-14
4:33 pm
Purchase
2021-12-31 13G Acorda Therapeutics, Inc.
ACOR
Point72 Asset Management, L.P. 23,214
4.100%
23,214increase
(New Position)
Filing
History
2022-02-14
4:32 pm
Purchase
2021-12-31 13G Viridian Therapeutics, Inc.
VRDN
Point72 Asset Management, L.P. 472,864
2.200%
46,702increase
(+10.96%)
Filing
History
2022-02-14
4:32 pm
Sale
2021-12-31 13G Golar LNG Limited
GLNG
Point72 Asset Management, L.P. 4,406,367
4.100%
-1,174,969decrease
(-21.05%)
Filing
History
2022-02-14
4:31 pm
Unchanged
2021-12-31 13G Bakkt Holdings, Inc.
BKKT
Point72 Asset Management, L.P. 0
0.000%
0
(Unchanged)
Filing
History
2022-02-14
4:31 pm
Sale
2021-12-31 13G Forte Biosciences, Inc.
FBRX
Point72 Asset Management, L.P. 44
0.100%
-27,798decrease
(-99.84%)
Filing
History
2022-02-14
4:29 pm
Purchase
2021-12-31 13G Avalo Therapeutics, Inc.
AVTX
Point72 Asset Management, L.P. 2,088
5.400%
1increase
(+0.05%)
Filing
History
2022-02-14
4:28 pm
Purchase
2021-12-31 13G Atara Biotherapeutics, Inc.
ATRA
Point72 Asset Management, L.P. 185,366
5.200%
2,645increase
(+1.45%)
Filing
History
2022-02-14
4:27 pm
Purchase
2021-12-31 13G Arcutis Biotherapeutics, Inc.
ARQT
Point72 Asset Management, L.P. 2,657,962
5.300%
107,226increase
(+4.20%)
Filing
History
2022-02-14
4:26 pm
Purchase
2021-12-31 13G Akero Therapeutics, Inc.
AKRO
Point72 Asset Management, L.P. 1,760,248
5.000%
8,685increase
(+0.50%)
Filing
History
2022-02-14
4:25 pm
Sale
2021-12-31 13G Aeglea BioTherapeutics, Inc.
AGLE
Point72 Asset Management, L.P. 2,244
0.100%
-114,948decrease
(-98.09%)
Filing
History
2022-02-11
5:05 pm
Purchase
2022-02-01 13G uniQure N.V.
QURE
Point72 Asset Management, L.P. 3,611,691
7.800%
3,143,854increase
(+672.00%)
Filing
History
2022-02-10
5:07 pm
Purchase
2022-01-31 13G FibroGen, Inc.
FGEN
Point72 Asset Management, L.P. 186,644
5.000%
186,644increase
(New Position)
Filing
History
2022-01-10
4:52 pm
Purchase
2022-01-07 13G BellRing Brands, Inc.
BRBR
Point72 Asset Management, L.P. 1,983,182
5.100%
1,983,182increase
(New Position)
Filing
History
2022-01-04
5:20 pm
Purchase
2022-01-03 13G Applied Therapeutics, Inc.
APLT
Point72 Asset Management, L.P. 2,556,976
9.800%
2,556,976increase
(New Position)
Filing
History
2021-12-21
5:13 pm
Purchase
2021-12-20 13G Atara Biotherapeutics, Inc.
ATRA
Point72 Asset Management, L.P. 182,721
5.200%
182,721increase
(New Position)
Filing
History
2021-12-15
5:14 pm
Purchase
2021-12-14 13G Arcutis Biotherapeutics, Inc.
ARQT
Point72 Asset Management, L.P. 2,550,736
5.100%
2,550,736increase
(New Position)
Filing
History
Goto Prev, 0, 1, ...13, 14, 15, 16, 17, 18, 19, Next